Eu2P is a European online education and training programme in pharmacovigilance and pharmacoepidemiology that delivers Master and PhD diplomas, and on-the-job training continuing education certificates or short courses.

Eu2P is a unique partnership of seven Universities, fifteen pharmaceutical companies, the French and the European medicines agencies. Eu2P is funded by the EU and the EFPIA through the Innovative Medicines Initiative.

- Eu2P academic partners
Université Bordeaux Segalen - France
Erasmus Universitair Medisch Centrum - The Netherlands
Fundació Institut Catalá de Farmacologia - Universitat Autonoma de Barcelona - Spain
University of Hertfordshire - United Kingdom
Universita di Verona - Italy
Utrecht Universiteit - The Netherlands
Karolinska Institutet - Sweden

- Eu2P regulatory partners
EMA (European Medicines Agency) - United Kingdom
ANSM (Agence nationale de sécurité du médicament et des produits de santé) - France

- Eu2P industrial partners
F. Hoffmann-La Roche Ltd - Switzerland
Amgen NV - Belgium
AstraZeneca AB - United Kingdom
Bayer HealthCare - Germany
Boehringer Ingelheim International GmbH - Germany
Eli Lilly and Company Limited - United Kingdom
GlaxoSmithKline Research and Development Ltd - United Kingdom
H. Lundbeck A/S - Denmark
Janssen Pharmaceutica NV - Belgium
Laboratorios Almirall SA - Spain
Novartis Pharma AG - Switzerland
Novo Nordisk A/S - Denmark
Orion Corporation - Finland
Sanofi-aventis Recherche et Développement - France
UCB Pharma SA - Belgium

Life Sciences

Pharmaceutical

Eu2P - European programme in Pharmacovigilance and Pharmacoepidemiology

Eu2P - European programme in Pharmacovigilance and Pharmacoepidemiology's headquarters in Bordeaux, France

Description

People

Jobs